Evidence map›Paper›PMID 35159166›Full record

ReviewCells2022

Notch Signaling in HSC Emergence: When, Why and How.

Roshana Thambyrajah, Anna Bigas

Abstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. ABlood vessels, thrombosis & hemostasis · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Inflammation in Development and Aging: Insights from the Zebrafish Model.International journal of molecular sciences · 2024
    Review
  15. Review
  16. Review
  17. The evolving hematopoietic niche during development.Frontiers in molecular biosciences · 2024
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Roshana ThambyrajahProgram in Cancer Research, Institut Hospital del Mar d'Investigacions Mèdiques, CIBERONC, 08003 Barcelona, Spain.ORCID 0000-0002-3941-760X
Anna BigasProgram in Cancer Research, Institut Hospital del Mar d'Investigacions Mèdiques, CIBERONC, 08003 Barcelona, Spain.ORCID 0000-0003-4801-6899

Funding

Agencia Estatal de Investigación, Spain PID2019-104695RB-I00Government of Catalonia 2017SGR135Government of Catalonia BP2016(00021)Government of Catalonia BP/MSCA 2018(00034)
6 · The paper itself

Abstract

The hematopoietic stem cell (HSC) sustains blood homeostasis throughout life in vertebrates. During embryonic development, HSCs emerge from the aorta-gonads and mesonephros (AGM) region along with hematopoietic progenitors within hematopoietic clusters which are found in the dorsal aorta, the main arterial vessel. Notch signaling, which is essential for arterial specification of the aorta, is also crucial in hematopoietic development and HSC activity. In this review, we will present and discuss the evidence that we have for Notch activity in hematopoietic cell fate specification and the crosstalk with the endothelial and arterial lineage. The core hematopoietic program is conserved across vertebrates and here we review studies conducted using different models of vertebrate hematopoiesis, including zebrafish, mouse and in vitro differentiated Embryonic stem cells. To fulfill the goal of engineering HSCs in vitro, we need to understand the molecular processes that modulate Notch signaling during HSC emergence in a temporal and spatial context. Here, we review relevant contributions from different model systems that are required to specify precursors of HSC and HSC activity through Notch interactions at different stages of development.

Indexed as

MesonephrosZebrafishAnimalsGonadsHematopoiesisHematopoietic Stem CellsMiceAGMdevelopmental hematopoiesisHSCNotch signaling

Identifiers

PMID35159166
PMCPMC8833884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.